Immunogenicity of the inactivated split-virion influenza vaccine administered by the intradermal route in renal transplant subjects.
Phase of Trial: Phase II
Latest Information Update: 13 Jan 2014
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors Sanofi
- 17 Sep 2009 Status changed from active, no longer recruiting to completed, according to results published at the 14th Congress of the European Society for Organ Transplantation.
- 02 Sep 2009 Results have been reported at the 14th Congress of the European Society for Organ Transplantation (ESOT 2009).
- 05 Mar 2008 New trial record.